|
|
|
|
|
by Thriptic
4337 days ago
|
|
I couldn't agree more with almost everything you just said (especially number 2). My only potential issue is with number 5. While I agree that raw data should be shared for purposes of reproducibility and progress, I can also partially sympathize with investigators who put in enormous time and effort to coordinate and run large studies / clinical trials. If investigators were forced to immediately release their raw data from these studies, there would be armies of other investigators swooping in to scoop the original team on follow on studies from the data. While this would certainly be great for science, it partially punishes investigators for actually conducting the large trials. I'm not sure how justifiable it would be to put in the effort to conduct a large clinical trial and then only get 1-2 papers out of it (even if they went into NEJM / JAMA / Lancet etc). What are your thoughts? |
|
[1] For those outside of science what happen now is groups with the data hold back the data and then use access to the data to establish “collaborations” - basically they will give you access to the data as long as you put their names on any resulting papers. The people with the data often don’t actually contribute anything to the new publication other than access to the data and their names - my old boss was a expert at doing this.